This early-phase trial tests whether giving stem cells (from a donor) during heart-lung bypass surgery is safe for infants under 6 months with certain congenital heart defects. Seventeen infants will receive the cells while undergoing heart repair. The main goal is to check for s…
Phase: PHASE1 • Sponsor: Catherine Bollard • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC